Christopher Franklin Devall A Ikido Pharma Inc. (AIKI) insider trading activity

AIKI Quotes by TradingView

Christopher Franklin Devall is COO of AIkido Pharma Inc.. Currently has a direct ownership of 30,033 shares of AIKI, which is worth approximately $114,125. The most recent transaction as insider was on Dec 26, 2023, when has been sold 7,000 shares (Common Stock) at a price of $2.55 per share, resulting in proceeds of $17,850. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 30K
0% 3M change
42.79% 12M change
Total Value Held $114,125

Christopher Franklin Devall Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 26 2023
BUY
Open market or private purchase
$17,850 $2.55 p/Share
7,000 Added 18.9%
30,033 Common Stock
Nov 30 2023
BUY
Open market or private purchase
$2,280 $2.28 p/Share
1,000 Added 4.16%
23,033 Common Stock
Nov 28 2023
BUY
Open market or private purchase
$2,260 $2.26 p/Share
1,000 Added 4.34%
22,033 Common Stock
May 18 2023
BUY
Open market or private purchase
$4,410 $2.94 p/Share
1,500 Added 6.66%
21,033 Common Stock
Apr 05 2023
BUY
Open market or private purchase
$19,999 $3.51 p/Share
5,698 Added 22.58%
19,533 Common Stock
CFD

Christopher Franklin Devall

COO
New York, NY

Track Institutional and Insider Activities on AIKI

Follow AIkido Pharma Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AIKI shares.

Notify only if

Insider Trading

Get notified when an A Ikido Pharma Inc. insider buys or sells AIKI shares.

Notify only if

News

Receive news related to AIkido Pharma Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on AIKI